SPONSOR
Masonic Cancer Center, University of Minnesota
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 1
Conditions studied: NeuroblastomaTri-specific Killer EngagerSolid TumorAdvanced Solid TumorAlcohol-Related CarcinomaFanconi AnemiaOral Cavity CarcinomaHematologic DisordersHemoglobinopathiesImmunodeficiencies
Masonic Cancer Center, University of Minnesota is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Neuroblastoma, Tri-specific Killer Engager, Solid Tumor, Advanced Solid Tumor.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Masonic Cancer Center, University of Minnesota
How many clinical trials has Masonic Cancer Center, University of Minnesota sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Masonic Cancer Center, University of Minnesota, of which 4 are actively recruiting participants. These trials cover conditions including Neuroblastoma, Tri-specific Killer Engager, Solid Tumor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Masonic Cancer Center, University of Minnesota research focus on?
Masonic Cancer Center, University of Minnesota clinical trials span Neuroblastoma, Tri-specific Killer Engager, Solid Tumor, Advanced Solid Tumor, Alcohol-Related Carcinoma, and additional conditions. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Masonic Cancer Center, University of Minnesota clinical trial?
To participate in a Masonic Cancer Center, University of Minnesota trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Masonic Cancer Center, University of Minnesota trials with current recruitment status updated daily.
Clinical Trials by Masonic Cancer Center, University of Minnesota
NCT02605421 Phase 2
Recruiting
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Neuroblastoma
NCT07541573 Phase 1
Recruiting
GTB-5550 in Advanced Solid Tumors
Tri-specific Killer Engager
NCT05973656
Recruiting
Role of Acetaldehyde in the Development of Oral Cancer
Alcohol-Related Carcinoma
NCT01666080
Recruiting
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Hematologic Disorders
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology